US stocks are poised to open lower in Friday's trading session as investors analyze better-than-expected inflation data released earlier in the morning. The stock markets saw a reduction in losses from earlier, with Dow Jones Industrial Average futures decreasing by 0.21%, S&P 500 futures falling by 0.48%, and Nasdaq futures moving down by 0.84%. Monthly core inflation for November increased by 0.1% compared to a 0.3% rise in October and fell short of expectations of a 0.2% increase, as reported by Bloomberg.
Additionally, the annual core inflation rate remained steady at 2.8%, compared to anticipated figures of 2.9%. Oil prices experienced a decline, with front-month global benchmarks Brent crude and West Texas Intermediate crude dropping by 0.69% and 2.48% respectively. Across other global markets, Japan's Nikkei index registered a decrease of 0.20%, Hong Kong's Hang Seng fell by 0.16%, and China's Shanghai Composite dropped by 0.06%.
Meanwhile, in early afternoon trading in Europe, the UK's FTSE 100 declined by 1.2%, while Germany's DAX and France's CAC decreased by 1.19% and 1.03% respectively. In equities, shares of My Size ($MYSZ) surged by 340% in Friday's premarket session, following a 21% increase the previous day. Nvni Group ($NVNI) shares soared by 98% after rising 317% just a day prior.
Shares of Psyence Biomedica ($PBM) increased by 44%, adding to a previous 61% gain. Aptose Biosciences ($APTO) saw a 66% rise after announcing that the Nasdaq Hearings Panel approved its request for an extension to meet the minimum bid price requirement for continued listing. Similarly, shares of Humacyte ($HUMA) advanced by 72% following news that the US Food and Drug Administration granted full approval for SYMVESS, a bioengineered human tissue designed for universal implantation. On the downside, shares of Molecular Templates ($MTEM) plummeted by 54% after announcing that its stock will be suspended from Nasdaq on December 26 due to non-compliance with multiple listing requirements.
Shares of Cyngn ($CYN.US) fell by 75% after experiencing a 4.7% drop the previous day. Hyzon Motors' ($HYZN) stock tumbled by 25% following notifications of pending layoffs for employees in Illinois and Michigan. Shares of PainReform ($PRFX) declined by 36% following a significant 410% gain on Thursday.
Additionally, shares of Bio-Path ($BPTH) saw a loss of 17% after a previous increase of 123%..